Literature DB >> 28597809

Discontinuation of contact precautions with the introduction of universal daily chlorhexidine bathing.

J A McKinnell1, S J Eells2, E Clark1, D D Rand1, G T Kiet1, R Macias-Gil2, J M Mendez2, S S Huang3, E N Milefchik1, L G Miller2.   

Abstract

Contact precautions are a traditional strategy to prevent transmission of methicillin-resistant Staphylococcus aureus (MRSA). Chlorhexidine bathing is increasingly used to decrease MRSA burden and transmission in intensive care units (ICUs). We sought to evaluate a hospital policy change from routine contact precautions for MRSA compared with universal chlorhexidine bathing, without contact precautions. We measured new MRSA acquisition in ICU patients and surveyed for MRSA environmental contamination in common areas and non-MRSA patient rooms before and after the policy change. During the baseline and chlorhexidine bathing periods, the number of patients (453 vs. 417), ICU days (1999 vs. 1703) and MRSA days/1000 ICU days (109 vs. 102) were similar. MRSA acquisition (2/453 vs. 2/457, P = 0·93) and environmental MRSA contamination (9/474 vs. 7/500, P = 0·53) were not significantly different between time periods. There were 58% fewer contact precaution days in the ICU during the chlorhexidine period (241/1993 vs. 102/1730, P < 0·01). We found no evidence that discontinuation of contact precautions for patients with MRSA in conjunction with adoption of daily chlorhexidine bathing in ICUs is associated with increased MRSA acquisition among ICU patients or increased MRSA contamination of ICU fomites. Although underpowered, our findings suggest this strategy, which has the potential to reduce costs and improve patient safety, should be assessed in similar but larger studies.

Entities:  

Keywords:  Chlorhexidine; MRSA; VRE; contact precautions; hospital epidemiology; hygeine and hospital infections; infection prevention

Mesh:

Substances:

Year:  2017        PMID: 28597809      PMCID: PMC5943043          DOI: 10.1017/S0950268817001121

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  20 in total

Review 1.  SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

Authors:  Carlene A Muto; John A Jernigan; Belinda E Ostrowsky; Hervé M Richet; William R Jarvis; John M Boyce; Barry M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  2003-05       Impact factor: 3.254

Review 2.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 3.  MRSA and the environment: implications for comprehensive control measures.

Authors:  N Cimolai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-14       Impact factor: 3.267

4.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

5.  Cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers.

Authors:  James A McKinnell; Sarah M Bartsch; Bruce Y Lee; Susan S Huang; Loren G Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2015-01       Impact factor: 3.254

Review 6.  Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities.

Authors:  J E Coia; G J Duckworth; D I Edwards; M Farrington; C Fry; H Humphreys; C Mallaghan; D R Tucker
Journal:  J Hosp Infect       Date:  2006-04-03       Impact factor: 3.926

7.  The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial.

Authors:  Michael W Climo; Kent A Sepkowitz; Gianna Zuccotti; Victoria J Fraser; David K Warren; Trish M Perl; Kathleen Speck; John A Jernigan; Jaime R Robles; Edward S Wong
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

8.  A clinical study comparing the skin antisepsis and safety of ChloraPrep, 70% isopropyl alcohol, and 2% aqueous chlorhexidine.

Authors:  John S Hibbard; Gayle K Mulberry; Ann R Brady
Journal:  J Infus Nurs       Date:  2002 Jul-Aug

Review 9.  Adverse outcomes associated with Contact Precautions: a review of the literature.

Authors:  Daniel J Morgan; Daniel J Diekema; Kent Sepkowitz; Eli N Perencevich
Journal:  Am J Infect Control       Date:  2009-03       Impact factor: 2.918

10.  Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus in an intensive care unit.

Authors:  James R Price; Tanya Golubchik; Kevin Cole; Daniel J Wilson; Derrick W Crook; Guy E Thwaites; Rory Bowden; A Sarah Walker; Timothy E A Peto; John Paul; Martin J Llewelyn
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

View more
  3 in total

1.  Patient to healthcare personnel transmission of MRSA in the non-intensive care unit setting.

Authors:  Gita Nadimpalli; Lyndsay M O'Hara; Lisa Pineles; Karly Lebherz; J Kristie Johnson; David P Calfee; Loren G Miller; Daniel J Morgan; Anthony D Harris
Journal:  Infect Control Hosp Epidemiol       Date:  2020-02-10       Impact factor: 3.254

2.  Optimizing Contact Precautions to Curb the Spread of Antibiotic-resistant Bacteria in Hospitals: A Multicenter Cohort Study to Identify Patient Characteristics and Healthcare Personnel Interactions Associated With Transmission of Methicillin-resistant Staphylococcus aureus.

Authors:  Lyndsay M O'Hara; David P Calfee; Loren G Miller; Lisa Pineles; Laurence S Magder; J Kristie Johnson; Daniel J Morgan; Anthony D Harris
Journal:  Clin Infect Dis       Date:  2019-09-13       Impact factor: 9.079

3.  Skin antiseptics in healthcare facilities: is a targeted approach necessary?

Authors:  Timothy L Wiemken
Journal:  BMC Public Health       Date:  2019-08-22       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.